About NEUCA
NEUCA is a company based in Torun (Poland) founded in 1990. NEUCA has completed 3 acquisitions, including ACP Pharma, OncoBay Clinical and Ortopedio.pl. NEUCA operates in a competitive market with competitors including AmerisourceBergen, Pelion, Polfa Tarchomin and Vitama, among others.
- Annual Revenue$3.8 B (USD)8.18as on Dec 31, 2025
- Net Profit$43.31 M (USD)0.87as on Dec 31, 2025
- EBITDA$100.32 M (USD)-0.85as on Dec 31, 2025
- Investors
- Investments & AcquisitionsACP Pharma
& 2 more
Apps and channels of NEUCA
its YouTube channel Grupa NEUCA has 783 subscribers and 30 videos.
Videos from NEUCA
The most watched videos on NEUCA's YouTube channel, Grupa NEUCA (783 subscribers). Click a video to play it here.
More on Grupa NEUCA.
Funding Insights of NEUCA
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of NEUCA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in NEUCA
NEUCA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for NEUCA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NEUCA
88 people are tracked at NEUCA (22 in leadership, 6 in board & advisors, 60 in team).
| Name | Role | Group |
|---|---|---|
Piotr Sucharski | CEO | Leadership |
Roman Dudzik | VP, Management Board | Leadership |
Daniel Wojtkiewicz | VP, Management Board | Leadership |
Krzysztof Miszewski | VP, Operations | Leadership |
Julita Czyżewska | VP, Management Board | Leadership |
Andrzej Zieliński | HR Group Director | Leadership |
Monika Kujawa | Service Management Director | Leadership |
Michał Janiszewski | Sourcing And Procurement Director | Leadership |
Magdalena Gisman | Technology & Operational Excellence Director In Clinical Trials (clinscience And Pratia) | Leadership |
MacIej Jurkun | Director Of The Clinical Research Department SMO | Leadership |
MacIej Guhs | Head Of Sales (independent Pharmacy Market) | Leadership |
Tomasz Nawrocki | Group Contract Manufacturing & Supply Chain Service Director | Leadership |
Witold Sadłowski | Head Of Information Technology Portfolio / CTO | Leadership |
Damian Dawid | IT Business Partner Obszaru Funkcji Wsparcia | Leadership |
Tomasz Fidos | IT Business Partner | Leadership |
Robert Grygier | Group Customer Development Director, Group Excom Member | Leadership |
Łukasz Pietrzak | Director Of Compensation And Employee Service | Leadership |
Paweł Bernat | Director Of Communications And Public Affairs | Leadership |
Patryk Link | Recruitment & Development Director | Leadership |
Marta Gil-Budzyńska | Starszy Partner Biznesowy HR (obszar: Sprzedaż, Zarządzanie Ofertą, Rozwój Relacji Z Klientem,it) | Leadership |
68 more people are available in the full profile.
Complete people profiles for NEUCA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of NEUCA
NEUCA is a publicly listed company on the GPW with ticker symbol NEU in Poland, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Sep 2004
- Listed onGPW: NEU
- Listed entityNEUCA S.A.
- Exchange sectorDistribution services
- ISINPLTRFRM00018
- Share price705.00 PLN · 2026-10-09
- Market capitalisation3,250,165,064.00 PLN
- Price to earnings16.6
- EPS (diluted, trailing year)42.45 PLN
- Dividend yield2.52%
- Volume (last session)1,802
Financials of NEUCA
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 13.64B PLN | 155.6M PLN | 360.4M PLN |
| 2024 | 12.61B PLN | 154.2M PLN | 363.5M PLN |
| 2023 | 11.81B PLN | 146.3M PLN | 365.9M PLN |
| 2022 | 11.23B PLN | 137.2M PLN | 329.9M PLN |
| 2021 | 9.86B PLN | 150.7M PLN | 269.2M PLN |
Detailed financial statements for NEUCA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NEUCA
NEUCA has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ACP Pharma, OncoBay Clinical and Ortopedio.pl.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical research lab services are provided by OncoBay Clinical. | oncobay.com | Raleigh, United States | 2020 | Jan 2023 | •••• | |
Online resources and tools are provided for sports card collectors. | ortopedio.pl | Torun, Poland | 2011 | Jan 2016 | •••• | |
A standalone pharmacy is operated by ACP Pharma in Warsaw. | acppharma.pl | Warsaw, Poland | 2002 | Jun 2014 | •••• |
Complete acquisition details for NEUCA
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NEUCA
6 dated milestones of NEUCA across 33 years, from founding to its latest funding, stage changes and deals.
- Founded NEUCA is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ACP Pharma.
- Acquisition Acquires Ortopedio.pl.
- Funding First funding round.
- Acquisition Acquires OncoBay Clinical.
Competitors of NEUCA
NEUCA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pelion, Polfa Tarchomin and Vitama, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| pelion.eu | 1990 | Lodz, Poland | – | – | Pelion is recognized as a leading healthcare company in Poland. | |
| polfa-tarchomin.com.pl | 1823 | Warsaw, Poland | – | – | Manufactures generic drugs, APIs, and supplements for public health and markets. | |
| vitama.pl | 2012 | Warsaw, Poland | – | – | Pharmaceutical products are distributed by Vitama in Poland. |
Detailed competitors of NEUCA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NEUCA
The website of NEUCA (neuca.pl) receives about 60.2K visits a month and ranks #383,712 among all websites worldwide, #212 in Public Health and Safety.
- Monthly visits60.2K
▼ 16.2% vs previous month
- Unique visitors27.5K
per month
- Global rank#383,712
among all websites
- Category rank#212
Health · Public Health and Safety
- Bounce rate23%
- Pages per visit4.4
- Average visit3 min 40 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with NEUCA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rynekaptek.pl | rynekaptek.pl | 100% | – | #2,802,377 | – |
aptekarska.pl | aptekarska.pl | 96% | – | – | – |
farmacol.com.pl | farmacol.com.pl | 87% | – | #2,177,604 | – |
nekk.pl | nekk.pl | 66% | – | – | – |
domlekow.pl | domlekow.pl | 63% | – | #3,588,471 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for NEUCA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Neuca
Complete news archive for NEUCA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NEUCA
10 companies that operate in the same segment as NEUCA (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NEUCA
NEUCA was founded in 1990 and raised its 1st funding round 28 years after it was founded.
NEUCA is headquartered in Torun, Poland. It is registered at Torun, Kuyavian-pomeranian Voivodeship, Poland.
Piotr Sucharski is the current CEO of NEUCA.
Annual revenue of NEUCA is $3.8B as on Dec 31, 2025.
NEUCA was established in 1990 and is headquartered in Torun, Poland. Operations are focused on the wholesale distribution of pharmaceuticals within the healthcare sector. Services include supply chain management for medicines and related products to pharmacies, hospitals, and other entities across the country. Leadership is provided by CEO Piotr Sucharski, with activities centered on efficient logistics and regulatory compliance in the Polish market. The companys domain is neuca.pl.
NEUCA's top competitors include AmerisourceBergen, Pelion and Vitama.
Yes, NEUCA is publicly traded on GPW under the ticker symbol NEU.
NEUCA has made 3 acquisitions, including ACP Pharma, OncoBay Clinical, and Ortopedio.pl.
NEUCA has 1 investor. Key investors include European Union.